Form 4: Cardlytics Director Andre J. Fernandez Reports Stock Transactions
SEC Form 4 Filing
Director Andre J. Fernandez reports the vesting and disposal of 11,000 restricted stock units into Cardlytics common stock on May 23, 2025.
Summary
- On May 23, 2025, Andre J. Fernandez, a director of Cardlytics, Inc., reported a transaction involving restricted stock units (RSUs).
- Mr. Fernandez disposed of 11,000 shares of common stock upon the vesting of 11,000 RSUs.
- The transaction was executed at a price of $0, indicating the vesting of the RSUs.
- Following the transaction, Mr. Fernandez directly owns 15,310 shares of Cardlytics common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, and does not inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings and transactions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/23/2025 | Date of the reported transaction involving the vesting and disposal of restricted stock units. |
Keywords
Cardlytics, Director, Form 4, Stock, RSU, Fernandez, CDLX, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.